Multi-hit lymphoma with intermediate features and novel t(3;8)(q27;q24) not involving MYC

References

• Kluin P, Harris N, Stein H, WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours. In: Swerdlow S, Campo E, Harris N, editors. Vol. 1. 4th ed. Lyon, France: International Agency for Research on Cancer (IARC); 2008 p 439.
   Google Scholar
• Carbone A, Gloghini A, Aiello A, Testi A, Cabras A. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol 2010;41:621–631.
   PubMed Web of Science ®Google Scholar
• Quintanilla-Martinez L, de Jong D, de Mascarel A, Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2009;2:211–236.
   PubMedGoogle Scholar
• Le Gouill S, Talmant P, Touzeau C, The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007;92:1335–1342.
   PubMed Web of Science ®Google Scholar
• Keller CE, Nandula S, Fisher J, The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations. Am J Clin Pathol 2008;130:193–201.
   PubMed Web of Science ®Google Scholar
• Savage KJ, Johnson NA, Ben-Neriah S, MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 2009;114:3533–3537.
   PubMed Web of Science ®Google Scholar
• Johnson NA, Savage KJ, Ludkovski O, Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 2009;114:2273–2279.
   PubMed Web of Science ®Google Scholar
• McClure RF, Remstein ED, Macon WR, Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol 2005;29:1652–1660.
   PubMed Web of Science ®Google Scholar
• Tomita N, Tokunaka M, Nakamura N, Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica 2009; 94:935–943.
   PubMed Web of Science ®Google Scholar
• Barrans S, Crouch S, Smith A, Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 2010;28:3360–3365.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kaneita Y, Aoki Y, Seto M, Mori S, Moriyama M. Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5′-RACE and LA – PCR analyses of biopsy samples. Oncogene 1999;18:7994–7999.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Greiner TC, Patel K, Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007;21:2332–2343.
   PubMed Web of Science ®Google Scholar
• Niitsu N, Nakamine H, Hagiwara Y, Tanae K, Miura I. The t(1;3)(p34;q27)translocation: a nonrandom BCL6 rearrangement in diffuse large B cell lymphoma. Ann Hematol 2008;87:151–153.
   PubMed Web of Science ®Google Scholar
• Wang H-Y, Bossler AD, Schaffer A, A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma. Cancer Genet Cytogenet 2007;172:45–53.
   PubMed Web of Science ®Google Scholar
• Einerson RR, Law ME, Blair HE, Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2. Leukemia 2006;20:1790–1799.
   PubMed Web of Science ®Google Scholar
• Bertrand P, Bastard C, Maingonnat C, Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 2007;21:515–523.
   PubMed Web of Science ®Google Scholar
• Gerbitz A, Mautner J, Geltinger C, Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma. Oncogene 1999;18:1745–1753.
   PubMed Web of Science ®Google Scholar
• Wittekindt NE, Hörtnagel K, Geltinger C, Polack A. Activation of c-myc promoter P1 by immunoglobulin κ gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs κB, E box 1 and E box 2, and of the 3′ enhancer motif PU. Nucleic Acids Res 2000;28:800–808.
   PubMed Web of Science ®Google Scholar
• Huppi K, Volfovsky N, Runfola T, The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res 2008;6:212–221.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Miyanishi S, Sonoki T, Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes. Int J Hematol 2004;79:474–479.
   PubMed Web of Science ®Google Scholar
• Fujii S, Miyata A, Takeuchi M, Yoshino T. [Acute lymphoblastic leukemia (L3) with t(2;3)(p12;q27), t(14;18) (q32;q21), and t(8;22)(q24;q11)]. Rinsho Ketsueki 2005;46: 134–140.
   PubMedGoogle Scholar
• Bacher U, Haferlach T, Alpermann T, Kern W, Schnittger S, Haferlach C. Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms. Genes Chromosomes Cancer 2011;50:43–50.
   PubMed Web of Science ®Google Scholar
• Au WY, Horsman DE, Gascoyne RD, Viswanatha DS, Klasa RJ, Connors JM. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004;45:519–528.
   PubMed Web of Science ®Google Scholar
• Ueda C, Nishikori M, Kitawaki T, Uchiyama T, Ohno H. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. Int J Hematol 2004;79:52–54.
   PubMed Web of Science ®Google Scholar
• Ueda C, Uchiyama T, Ohno H. Immunoglobulin (Ig)/BCL6 versus non-Ig/BCL6 gene fusion in diffuse large B-cell lymphoma corresponds to a high- versus low-level expression of BCL6 mRNA. Blood 2002;99:2624–2625.
   PubMed Web of Science ®Google Scholar